PrimeRFP
PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91018F00079Hhsn261201500003i; hhsn26100079 — Leidos Biomedical Research, Inc

Leidos Biomedical Research, Inc holds $2.1B across 186 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent HHSN261201500003I. PoP ended Aug 25, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Nih Nci
Awarding office
Leidos Biomedical Research, Inc
Recipient
Aug 25, 2023
PoP end
$0
Obligated
$58.1M
Potential
561210
NAICS
M1HA
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Leidos Biomedical Research, Inc — $90

Contract facts

Federal
Contract number75N91018F00079
Also listed asHHSN261201500003I-75N91018F00079
AgencyNih Nci
Awarding officeNih Nci
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentLeidos Biomedical Research, Inc
CAGE3LYK6
UEIHV8BH9BPG8Y9
NAICS561210

No full NAICS 561210 intel page yet. Browse NAICS intelligence

PSCM1HA
Parent IDIQ / IDVHHSN261201500003I
Place of performanceFREDERICK MD
Pricing typeCost Plus Fixed Fee
Extent competedNot Competed
Related solicitationN01CO5240180
PoP startSep 22, 2018
PoP end (current)Aug 25, 2023
Obligated$0
Current value$58.1M
Potential value$58.1M

HHSN261201500003I; HHSN26100079; 400.001.0079.0001; NCI OD-FREDERICK; ROYALTY; B539 PHASE 2 REFURBISHMENT; 9/24/2018-9/11/2022 is a federal award for Nih Nci held by Leidos Biomedical Research, Inc. Estimated value $58.1M ($0 obligated). Current period of performance ends Aug 25, 2023. Place of performance: FREDERICK MD. Related solicitation N01CO5240180.

HHSN261201500003I; HHSN26100079; 400.001.0079.0001; NCI OD-FREDERICK; ROYALTY; B539 PHASE 2 REFURBISHMENT; 9/24/2018-9/11/2022

Recompete timing

Public
● Past PoP end (1109 days ago)

Current PoP ended Aug 25, 2023 (1109 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Leidos Biomedical Research, Inc — $2.1B obligated across 186 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$2.1B · 100% of firm total
Open full company profile →

Related awards

Same parent · incumbent
75N91021F00017
ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT
$12.1M
Sep 15, 2026
75N91021F00016
DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS
$6.6M
Sep 15, 2026
75N91021F00018
INFRASTRUCTURE IMPROVEMENTS
$4.6M
Sep 24, 2026
HHSN26100039
RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS (MOONSHOT)
$21.3M
Sep 30, 2026
75N91018F00080
HHSN261201500003I; HHSN26100080; 400.001.0080.0001; NCI OD-FREDERICK; APPROPRIATED; 125073…
$10.0M
Oct 2, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N91018F00079?

75N91018F00079 (Hhsn261201500003i; hhsn26100079) is a Nih Nci award with a potential value of $58.1M, currently held by Leidos Biomedical Research, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91018F00079?

Nih Nci awarded 75N91018F00079 to Leidos Biomedical Research, Inc (potential $58.1M).

Who is the incumbent on 75N91018F00079?

Leidos Biomedical Research, Inc is the incumbent with $2.1B across 186 related awards in SCOUT’s public footprint. The current period of performance ends Aug 25, 2023.

When does Leidos Biomedical Research, Inc’s 75N91018F00079 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 25, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91018F00079 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91018F00079